Episode Details

David Klein, CEO of Canopy Growth (NASDAQ: CGC), joins us to discuss the latest earnings numbers for Q2 2025. The cannabis company reported a 32% revenue increase for its popular ancillary brand, Storz & Bickel. Additionally, medical cannabis sales revenue grew 16% in Canada and 12% in international markets. Net revenue was down 9% quarter-over-quarter, while margins improved across the board. We’ll discuss all of this, plus find out what contributed to the softness in top-line growth, along with Klein’s main objectives for the company between now and his planned retirement in March 2025. #canooygrowth #cannabis #cannabisstocks #cannabisindustry #msos #stocks Want to see more from Canopy Growth?    • Cannabis industry: Canopy Growth CEO ...     • Canopy Growth CEO Comments on Latest ...   Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter! https://newsletter.thedalesreport.com... Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web: Facebook:   / thedalesreport   Twitter:   / thedalesreport   Instagram:   / dalesreport   Apple Podcasts: https://tinyurl.com/TDRTradet